Bosnia and Herzegovina - Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics
Since 2014, Bosnia and Herzegovina Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics grew 7% year on year. In 2019, the country was number 23 among other countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics at €93,347,743.28. Bosnia and Herzegovina is overtaken by Lithuania, which was number 22 at €119,740,673.33 and is followed by Macedonia at €69,643,721.28. Germany ranked the highest with €16,376,860,638.2 in 2019, +0.5% compared to 2018. Ireland, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Sweden witnessed the best average annual growth at +62.7% per year, while Montenegro was the worst growing country at -6.3% per year.
Loading...
| Date | Euros |
|---|---|
| 2019 | 93,347,743.28 |
| 2018 | 91,500,587.00 |
| 2017 | 90,953,830.00 |
| 2016 | 93,358,887.00 |
| 2015 | 68,848,029.00 |
How does Bosnia and Herzegovina rank in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics?
| # | 29 Countries | Euros | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
16,376,860,638.20 | 2019 | +0.5 % | +3.5 % | View data | |
| 2 |
#2
Ireland
|
14,139,386,320.45 | 2019 | +21.9 % | -5.8 % | View data | |
| 22 |
#22
Lithuania
|
119,740,673.33 | 2019 | +16.2 % | -1.6 % | View data | |
| 23 |
#23
Bosnia and Herzegovina
|
93,347,743.28 | 2019 | +2.0 % | +7.0 % | View data | |
| 24 |
#24
Macedonia
|
69,643,721.28 | 2019 | -1.0 % | +3.7 % | View data | |